logo
15:57 Dec 05

Sequent Scientific Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
199.70
-7.73 (-3.73%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Sequent Scientific Ltd. Financials

Sequent Scientific Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
199.70
-7.73 (-3.73%)
15:57 Dec 05
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

49/100
Technically Neutral

Strength

12

Weakness

6

Opportunity

0

Threats

1

3.10 %

ROE %

1.36 %

ROA %

1.77

EPS

28.14

BVPS

1.41 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1412.82 1420.91 1369.73 1551.37 1657.92
Operating Expenses +
1303.43 1408.95 1308.31 1389.57 1469.31
Raw Material
842.41 814.87 789.21 829.94 867.04
Increase Decrease in Cost
-49.42 18.9 -29.46 -18.09 -17.12
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
231.37 258.38 250.57 281.12 312.79
Miscellaneous Expenses
622.85 560.34 649.07 721.74 306.6
Operating Profit
109.39 11.96 61.42 161.8 188.61
Other Income
10.84 6.39 10.96 14.69 13.52
Depreciation
51.08 55.69 61.54 66.45 63.69
Interest
15.77 35.52 48.09 60.75 57.75
Profit before tax and exceptio..
53.39 -72.86 -37.26 49.28 80.69
Exceptional Items
0 -64.79 -17.39 -4.98 -3.6
PBT
53.39 -137.66 -54.65 44.31 84.29
Provision for Taxation
8.33 -15.68 -25.03 12.05 23.06
Net Profit
45.06 -121.98 -29.61 32.26 54.03
NET Profit after MI
41.25 -121.16 -35.87 21.88 44.85
EPS
1.65 -4.88 -1.44 0.85 1.67
Operating Profit Margin (%)
7.74 0.84 4.48 10.43 11.38
Net Profit Margin (%)
2.92 -8.53 -2.62 1.41 2.71

Sequent Scientific Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 52.30 52.60 52.60 52.60 52.80 52.80
FII 5.90 6.20 6.00 6.10 6.40 5.70
Public 12.90 12.90 12.90 12.00 10.00 8.10
Others 28.90 28.30 28.50 29.30 30.80 33.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: